Of approximately 4,000 affected genes, 59% are upregulated while 41% are downregulated, generally shifting expression patterns from diseased toward healthier states
This piece works through all of it: mechanism, selectivity, off-target signaling, pulsatile GH dynamics, and where each compound actually earns its place in a well-designed protocol
The analysis also showed GLP-1 users had elevated claims activity in certain arthritic conditions, thyroid and esophageal disorders, and sleep-wake disorders
Non-alcoholic fatty liver disease (NAFLD): Some GLP-1 medications have been approved for use in patients managing this condition
Precision Medicine : Tailoring treatments based on tumor metabolism profiles can improve outcomes
Endocr Rev 40, 1163-1185 (2019)